v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Total revenue $ 37,710 $ 32,501 $ 94,049 $ 56,191
Operating expenses:        
Cost of goods sold (including related party amounts of $1,711, $2,046, $4,795, and $3,400, respectively) 10,098 8,191 29,230 14,269
Research and development (including related party amounts of $551, $559, $1,830, and $1,804, respectively) 18,263 2,751 27,297 9,738
Selling, general and administrative (including related party amounts of $101, $123, $362, and $354, respectively) 43,520 74,751 193,303 170,167
Total operating expenses 71,881 85,693 249,830 194,174
Loss from operations (34,171) (53,192) (155,781) (137,983)
Interest income 1,136 2,097 4,709 8,065
Interest expense (including related party amounts of $127, $3, $373, and $3, respectively) (2,552) (56) (7,472) (56)
Total other (expense) income, net (1,416) 2,041 (2,763) 8,009
Net loss (35,587) (51,151) (158,544) (129,974)
Unrealized gains (losses) on available-for-sale securities 36 39 (229) (227)
Comprehensive loss $ (35,551) $ (51,112) $ (158,773) $ (130,201)
Net loss per share, Basic $ (0.36) $ (0.52) $ (1.59) $ (1.32)
Net loss per share, Diluted $ (0.36) $ (0.52) $ (1.59) $ (1.32)
Weighted-average shares outstanding used in computing net loss per share, basic 99,685,424 98,807,600 99,432,878 98,412,739
Weighted-average shares outstanding used in computing net loss per share, Diluted 99,685,424 98,807,600 99,432,878 98,412,739
Product revenue, net        
Revenue:        
Total revenue $ 33,414 $ 31,300 $ 77,076 $ 51,863
Revenue under collaboration agreements        
Revenue:        
Total revenue 1,661 55 4,207 2,859
Revenue under supply agreements        
Revenue:        
Total revenue $ 2,635 $ 1,146 $ 12,766 $ 1,469